Compare JFIN & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JFIN | KRMD |
|---|---|---|
| Founded | 2011 | 1980 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 201.5M | 186.5M |
| IPO Year | 2018 | 2019 |
| Metric | JFIN | KRMD |
|---|---|---|
| Price | $4.05 | $4.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.50 |
| AVG Volume (30 Days) | 75.3K | ★ 92.8K |
| Earning Date | 06-03-2026 | 05-06-2026 |
| Dividend Yield | ★ 17.47% | N/A |
| EPS Growth | N/A | ★ 53.85 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $41,127,366.00 |
| Revenue This Year | N/A | $20.32 |
| Revenue Next Year | N/A | $17.37 |
| P/E Ratio | $1.35 | ★ N/A |
| Revenue Growth | N/A | ★ 22.23 |
| 52 Week Low | $3.70 | $2.91 |
| 52 Week High | $18.70 | $6.61 |
| Indicator | JFIN | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 42.97 | 47.19 |
| Support Level | $3.80 | $3.95 |
| Resistance Level | $4.54 | $4.28 |
| Average True Range (ATR) | 0.23 | 0.14 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 36.98 | 26.03 |
Jiayin Group Inc is China's technology service group. It is an enterprise engaged in technological innovation services. It is committed to using big data, cloud computing, artificial intelligence and other technologies to connect consumers and financial institutions in consumption scenarios so that every user can enjoy efficient and convenient technology services. The company has engraved technological innovation into the company's development genes since its establishment, adheres to the dual drive of digital plus technology, and focuses on building a cloud service platform and intelligent risk control system with big data drive as the core concept.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.